IGF2BP1 and cancer: The criteria for selecting genes as target candidates comprised a consistent downregulation upon IGF2BP1 knockdown in several cancer-derived cell lines, a positive expression correlation with IGF2BP1 in tumors as well as reported IGF2BP1 binding sites [35].